Analysts/Institutional Investor Meet/Con. Call Updates

· - "". OrchidPharm~W -- A Dhanuka Group Company ---------------------------------- August 20, 2026 National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai-400051 Dalal Street, Fort, Mumbai-400001 Symbol: ORCHPHARMA Scrip Code: 524372 Ref: (i) Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (ii) SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026 Sub: Investors Presentation- Ouarter I of F.Y. 2026-27, ended on June 30, 2026 - Orchid Pharma Limited ("the Company") Dear Sir/Madam, With reference to the captioned subject and pursuant to Regulation 30, Sub- Para 15 of Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended read with SEBI Circular no. SEBI/HO/CFD/CFD-PoD- 2/CIR/P/2024/185 dated December 31, 2024 and in continuation to our earlier intimation, dated August 17, 2026, regarding the Analysts/Investors Earning Call scheduled to be held on August 21, 2026 at 03:00 P.M. (1ST), please find enclosed the Investors Presentation, inter-alia, including the financial performance of the Company for the Quarter-I of Financial Year 2026-27, ended on June 30, 2026. The Investor Presentation is also made available on the website of the Company at https:llwww.orchidpharma.com/investors You are requested to take the above intimation on record. Thanking You, For Orchid Pharma Limited Kapil Dayya Company Secretary & Compliance Officer Mem. No.- F10698 Encl. as above +91-44-27444471/72/73 corporate@orchidpharma.com orchidpharma.com CIN: L24222TN1992PLC022994 Registered Office: Corporate Office: Orchid Pharma Limited 15th Floor, Tower 1, DLF Corporate Greens, Sector 74A, Plot Nos. 121-128, 128A-133, 138-151,159-164, SIDCO Industrial Estate, Gurugram - 122004, Haryana, India Alathur, Chengalpattu Dist - 603110, Tamil Nadu, India. ( “ ”) ( Dhanuka Laboratories Ltd. amalgamated into Orchid Pharma Ltd. under the NCLT-sanctioned Scheme. ( ) - - % % + % - % - % + % + % - % % % % % % : ( ) & ( ) Q1 FY27 Q1 FY26 FY26 Particulars Jun 2026 Jun 2025 Year ended ( ) ( ) /( ) & ( ) – – ( ) /( ) ( ) /( ) & – – – /( ) ( ) ( ) ( ) — & (₹) ( ) & ( ) Q1 FY27 Q1 FY26 FY26 Particulars Jun 2026 Jun 2025 Year ended ( ) ( ) /( ) & ( ) – – ( ) /( ) ( ) – ( ) /( ) & ( ) /( ) ( ) ( ) ( ) — & (₹) ( )